Back to search

Italy· 039962079

CEFPODOXIMA SANDOZ

A cefpodoxime product containing cefpodoxima, registered in Italy by SANDOZ S.P.A., on the national reimbursement list. The same ATC class is registered in 6 of our 19 countries.

Reimbursed in Italy (AIFA class A)ATC J01DD13

Checked against AIFA (Italy) on

Informational only — not a medical device.

SOURCE REGISTER · ITAIFA (Italy)normalisedCEFPODOXIMA SANDOZATCJ01DD13REGISTER NO.039962079PACKS LISTED1CHECKEDSeptember 28, 2026

Where it is registered

Cefpodoxime is registered in 6 of 19 countries.

Countries holding a registration under ATC J01DD13 (cefpodoxime), each read from that country’s own register.

  • This record: Italy, from AIFA (Italy)
  • 4 of them publish a price we can compare per daily dose

Cefpodoxime · ATC J01DD13

6 / 19 countries

  • Czechiaprice
  • Finlandprice
  • Germany
  • Italyprice
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of cefpodoxime costs, country by country.

Normalised to the WHO defined daily dose (0.4 g), the median price runs from $3.33 in Italy to $8.39 in Switzerland — a ×2.5 gap.

  • Italy: $3.33 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown

Cefpodoxime · price per daily dose (0.4 g)

USD · FX 28 Sept 2026

  • CH Switzerland$8.39
  • IT Italy$3.33
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

AIFA (Italy)
Active substance
Cefpodoxima
Manufacturer
SANDOZ S.P.A.
Country
Italy (IT)
ATC code
J01DD13
ATC class
Cefpodoxime
Defined daily dose
0.4 g, O
Reimbursed
Yes
Source register
AIFA (Italy)
Last checked
September 28, 2026

Packs & prices · 1

1 priced
  • aic
    039962079
    "200 MG COMPRESSE RIVESTITE CON FILM" 6 COMPRESSE IN BLISTER AL/AL
    EUR 8.77

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

113 interactions on record for cefpodoxime.

Graded by severity as the source publishes them — 45 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Cefpodoxime · interactions on record

113 records

  • 45 moderate
  • 68 info

Most severe, free to view

  • Magnesium carbonateA02AA01moderate
  • Magnesium oxideA02AA02moderate
  • Magnesium hydroxideA02AA04moderate
  • Kombinationen von AluminiumsalzenA02AB10moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Cefpodoxime in 5 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All cefpodoxime products

Authorised across Europe · EMA

The same active substance is authorised in 10 EEA countries. Names it is sold under:

  • Austria · Biocef
  • Bulgaria · Ximebac, Фоксеро
  • Czechia · Forexo
  • Germany · Cefpodoxim 1 A Pharma, Cefpodoxim Al
  • France · Cefpodoxime Biogaran, Cefpodoxime Cristers Pharma
  • United Kingdom (Northern Ireland) · Cefpodoxime Proxetil, Cefpodoxime Proxetil Sandoz
  • Croatia · Rexocef
  • Portugal · Cefpodoxima Alkaloid
  • Romania · Forexo
  • Slovenia · Trexodo

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AIFA (Italy). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d0e2fa34-174c-4703-b9fc-f2c691e505c7
GET /v1/drugs/d0e2fa34-174c-4703-b9fc-f2c691e505c7?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "pack": "\"200 MG COMPRESSE RIVESTITE CON FILM\" 6 COMPRESSE IN BLISTER AL/AL",
  "source": "aifa",
  "currency": "EUR",
  "substance": "Cefpodoxima",
  "reference_pack": "6 UNITA' 200 MG - USO ORALE",
  "public_price_eur": 8.77,
  "ssn_reference_price_eur": 8.77
}

See everything about cefpodoxime.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.